Crossmark

[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma

Crossref DOI link: https://doi.org/10.1016/j.farma.2024.09.006

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lorente Fernández, Laura

Romero Domínguez, Samuel

Albert Marí, Asunción

Núñez Benito, Esperanza

López Briz, Eduardo

Poveda Andrés, José Luis
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2024-09-17
More Information

This article is maintained by: Elsevier

Article Title: [Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma

Journal Title: Farmacia Hospitalaria

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.farma.2024.09.006

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.farma.2024.04.020

Content Type: article

Copyright: Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Farmacia Hospitalaria (S.E.F.H).